↓ Skip to main content

Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

Overview of attention for article published in Cochrane database of systematic reviews, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Average Attention Score compared to outputs of the same age and source

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
262 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Published in
Cochrane database of systematic reviews, October 2014
DOI 10.1002/14651858.cd005590.pub3
Pubmed ID
Authors

Anat Stern, Hefziba Green, Mical Paul, Liat Vidal, Leonard Leibovici

Abstract

Pneumocystis pneumonia (PCP) is a disease affecting immunocompromised patients. PCP among these patients is associated with significant morbidity and mortality.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 262 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Japan 2 <1%
Switzerland 2 <1%
Spain 1 <1%
Qatar 1 <1%
Germany 1 <1%
United States 1 <1%
Unknown 252 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 39 15%
Other 39 15%
Researcher 35 13%
Student > Postgraduate 34 13%
Student > Bachelor 31 12%
Other 84 32%
Readers by discipline Count As %
Medicine and Dentistry 169 65%
Unspecified 33 13%
Nursing and Health Professions 13 5%
Agricultural and Biological Sciences 10 4%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Other 27 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2019.
All research outputs
#1,931,433
of 13,586,571 outputs
Outputs from Cochrane database of systematic reviews
#4,591
of 10,644 outputs
Outputs of similar age
#31,249
of 211,272 outputs
Outputs of similar age from Cochrane database of systematic reviews
#113
of 225 outputs
Altmetric has tracked 13,586,571 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,644 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,272 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.